← back to search

James J.H. Chong

The University of Sydney · AU
Area of research
Cardiology and Cardiovascular Medicine · Molecular Biology
Research interest
Research interests include Tissue Engineering and Regenerative Medicine, Cardiac Fibrosis and Remodeling, Congenital heart defects research, and Cardiac electrophysiology and arrhythmias.
h-index
25
citations
4,024
works
149
NIH funding
primary concept
email

Recent publications

Myocardial Infarction in the Young: Aetiology, Emerging Risk Factors, and the Role of Novel Biomarkers
Journal of Cardiovascular Development and Disease 2025cited by 13position: middledoi
Integration mapping of cardiac fibroblast single-cell transcriptomes elucidates cellular principles of fibrosis in diverse pathologies
Science Advances 2024cited by 53position: middledoi
Cellular heterogeneity of pluripotent stem cell-derived cardiomyocyte grafts is mechanistically linked to treatable arrhythmias
Nature Cardiovascular Research 2024cited by 32position: lastdoi
Vascular cells improve functionality of human cardiac organoids
Cell Reports 2023cited by 119position: middledoi
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
Nature Communications 2022cited by 82position: middledoi
Tropoelastin Improves Post-Infarct Cardiac Function
Circulation Research 2022cited by 31position: lastdoi
Role of PDGF-A/B Ligands in Cardiac Repair After Myocardial Infarction
Frontiers in Cell and Developmental Biology 2021cited by 56position: middledoi
Platelet-derived growth factor-AB improves scar mechanics and vascularity after myocardial infarction
Science Translational Medicine 2020cited by 77position: lastdoi
Mesenchymal Stem Cells in Cardiac Repair: Effects on Myocytes, Vasculature, and Fibroblasts
Clinical Therapeutics 2020cited by 30position: lastdoi
Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia
Nature Communications 2019cited by 415position: middledoi
Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study
BMJ Open 2019cited by 57position: middledoi
Comparison of Human Embryonic Stem Cell-Derived Cardiomyocytes, Cardiovascular Progenitors, and Bone Marrow Mononuclear Cells for Cardiac Repair
Stem Cell Reports 2015cited by 109position: middledoi
Cardiac regeneration using pluripotent stem cells—Progression to large animal models
Stem Cell Research 2014cited by 96position: firstdoi
Stem cell therapy for cardiac dysfunction
SpringerPlus 2014cited by 42position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Halina Leung · The University of Sydney2 papers (2019–2022)Fairooj N. Rashid · The University of Sydney2 papers (2022–2022)Zohra Ahmadi · UNSW Sydney2 papers (2019–2022)Charles E. Murry · University of Southern California2 papers (2014–2015)Beng H. Chong · The University of Texas Southwestern Medical Center2 papers (2019–2022)José Perdomo · UNSW Sydney2 papers (2019–2022)Robert D. Hume · The University of Sydney2 papers (2022–2024)Clara K Chow · National Health and Medical Research Council2 papers (2019–2025)Nona Farbehi · UNSW Sydney1 papers (2021–2021)Tejas Deshmukh · The University of Sydney1 papers (2022–2022)Gordon Keller · University Health Network1 papers (2015–2015)Amer Matar · Coffs Harbour City Council1 papers (2014–2014)Shiying Silvia Zheng · UNSW Sydney1 papers (2022–2022)Joerg Eberhard · The University of Sydney1 papers (2021–2021)Stephen T. Vernon · The University of Sydney1 papers (2019–2019)Juntang Lu · Westmead Hospital1 papers (2022–2022)Stephen B. Ting · Eastern Health1 papers (2022–2022)Freda Passam · The University of Sydney1 papers (2019–2019)Richard P. Harvey · Victor Chang Cardiac Research Institute1 papers (2024–2024)Hans Reinecke · California Institute for Regenerative Medicine1 papers (2015–2015)